HealthWarehouse.com, Inc.

As of March 31, 2026, HealthWarehouse.com, Inc. carries a market capitalization of 6.83M, placing it among publicly traded companies globally. Its enterprise value stands at 8.25M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, HealthWarehouse.com, Inc. has 56.95M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.17, and the price-to-book ratio stands at -1.90.

As of March 31, 2026, HealthWarehouse.com, Inc. trades at an EV/EBITDA multiple of 22.87 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.20 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 8.25M versus a market cap of 6.83M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, HealthWarehouse.com, Inc. maintains a current ratio of 0.66, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -80.26, indicating conservative leverage, while an interest coverage ratio of 7.05 demonstrates adequate ability to service its debt obligations.

These figures cover the twelve months ended March 31, 2026. Return on assets (ROA) is negative at -2.77, reflecting losses generated across the asset base. The company generates approximately 378,448.69 in revenue per employee across its workforce of 106.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 8.68 indicates how many times HealthWarehouse.com, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, HealthWarehouse.com, Inc. recorded 12,760.00 in income tax expense. The company reported a pretax loss of -261,104.00 and -273,864.00 in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, HealthWarehouse.com, Inc.'s stock has declined approximately 59.83% over the past 52 weeks. The 50-day moving average sits at 0.12, while the 200-day moving average is 0.11.

Over the twelve months ended March 31, 2026, HealthWarehouse.com, Inc. generated 40.30M in revenue and converted that into -273,864.00 in net income, yielding earnings per share of 0.00. EBITDA reached 360,964.00, while operating income came in at -163,926.00.

As of March 31, 2026, HealthWarehouse.com, Inc. holds 1.46M in cash and equivalents against 2.89M in total debt, resulting in a net debt position of 623,786.00. Total book value stands at -3.60M, with working capital of -1.72M providing operational flexibility.

HealthWarehouse.com, Inc. produced -5.34M in operating cash flow over the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, HealthWarehouse.com, Inc. posted a gross margin of 39.46, reflecting its pricing power and cost economics. The operating margin of -0.41 and net profit margin of -0.68 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. The dividend payout ratio of 55.55 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -67.35: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

HealthWarehouse.com, Inc.'s most recent stock split took place on July 29, 2010 with a 20:1 split ratio.

As of March 31, 2026, HealthWarehouse.com, Inc. has an Altman Z-Score of -3.37, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.